COMPOUND_XXX BASE was administered percutaneously to SD rats at dose levels of 5 , 15 and 50 mg / kg / d for 4 weeks to investigate the potential repeated dose toxicity .
COMPOUND_XXX BASE was administered percutaneously to SD rats at dose levels of 5 , 15 and 50 mg / kg / d for 4 weeks to investigate the potential repeated dose toxicity .
O O O O O O O O O O O O B-DOSE I-DOSE I-DOSE I-DOSE I-DOSE I-DOSE I-DOSE I-DOSE I-DOSE I-DOSE O O O O O O O O O O O